Ipsen and Marengo Therapeutics are expanding a deal to include two trispecific antibody assets that tackle so-called cold tumors, which do not typically respond well …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
The FDA handed a complete response letter (CRL) on Wednesday to Merck for its cough drug gefapixant following an adcomm that voted against the drug
A 10-person startup called Marea said Tuesday that it had raised $190 million to help develop a drug to lower a type of cholesterol — what
Researchers have identified a previously unrecognized class of antibodies-;immune system proteins that protect against disease-;that appear capable of neutralizing multiple forms of flu virus.